SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-198663
Filing Date
2021-06-24
Accepted
2021-06-24 16:12:30
Documents
65
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d912674d10q.htm 10-Q 904222
2 EX-31.1 d912674dex311.htm EX-31.1 9878
3 EX-31.2 d912674dex312.htm EX-31.2 9869
4 EX-32.1 d912674dex321.htm EX-32.1 4378
5 EX-32.2 d912674dex322.htm EX-32.2 4369
  Complete submission text file 0001193125-21-198663.txt   4289204

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vera-20210331.xml EX-101.INS 664217
7 XBRL TAXONOMY EXTENSION SCHEMA vera-20210331.xsd EX-101.SCH 51155
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vera-20210331_cal.xml EX-101.CAL 32093
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vera-20210331_def.xml EX-101.DEF 245544
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vera-20210331_lab.xml EX-101.LAB 376725
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vera-20210331_pre.xml EX-101.PRE 310661
Mailing Address 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40407 | Film No.: 211042972
SIC: 2834 Pharmaceutical Preparations